EVALUATION OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO FIRST-GENERATION JANUS KINASE INHIBITORS

被引：0
|
作者：
Kamiya, M. [1 ]
Mori, S. [1 ]
Yamazaki, K. [1 ]
Togawa, D. [1 ]
机构：
[1] Kindai Univ, Nara Hosp, Dept Orthopaed & Rheumatol, Ikoma, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.650
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0670
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [41] Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
    Kotyla, Przemyslaw J.
    Islam, Md Asiful
    Engelmann, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 17
  • [42] Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients
    Kurushima, Shota
    Koga, Tomohiro
    Umeda, Masataka
    Iwamoto, Naoki
    Miyashita, Ritsuko
    Tokito, Takatomo
    Okuno, Daisuke
    Yura, Hirokazu
    Ishimoto, Hiroshi
    Kido, Takashi
    Sakamoto, Noriho
    Ueki, Yukitaka
    Mukae, Hiroshi
    Kawakami, Atsushi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
    Temmoku, Jumpei
    Miyata, Masayuki
    Suzuki, Eiji
    Sumichika, Yuya
    Saito, Kenji
    Yoshida, Shuhei
    Matsumoto, Haruki
    Fujita, Yuya
    Matsuoka, Naoki
    Asano, Tomoyuki
    Sato, Shuzo
    Migita, Kiyoshi
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [44] Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis
    Anno, Shohei
    Okano, Tadashi
    Mamoto, Kenji
    Yamada, Yutaro
    Mandai, Koji
    Orita, Kazuki
    Iida, Takahiro
    Tada, Masahiro
    Inui, Kentaro
    Koike, Tatsuya
    Nakamura, Hiroaki
    MODERN RHEUMATOLOGY, 2024, 35 (02) : 225 - 233
  • [45] Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Gregory
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 856 - 857
  • [46] Outcomes in Patients with Rheumatoid Arthritis Initiating Monotherapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
    Pappas, Dimitrios
    O'Brien, Jacqueline
    Kelleman, Mike
    Guo, Lin
    Shan, Ying
    Baker, Joshua
    Kricorian, Greg
    Stryker, Scott
    Collier, David
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2798 - 2800
  • [47] Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis
    Ebina, Kosuke
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 256 - 262
  • [48] OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING THERAPY WITH ETANERCEPT, ADALIMUMAB, OR JANUS KINASE INHIBITORS
    Pappas, D. A.
    O'brien, J.
    Guo, L.
    Shan, Y.
    Baker, J.
    Kricorian, G.
    Stryker, S.
    Collier, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 529 - 530
  • [49] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [50] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
12345